State Street’s Neuraxis NRXS Stock Holding History

State Street’s Portfolio NRXS Stock Details NRXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$352K	Buy	47,737 +3,500	+8%	+$23.2K	﹤0.01%	3754
2026 Q2	$323K	Buy	44,237 +5,700	+15%	+$42.1K	﹤0.01%	3763
2026 Q1	$285K	Buy	38,537 +8,000	+26%	+$43.8K	﹤0.01%	3800
2025 Q4	$139K	Buy	+30,537	New	+$91.3K	﹤0.01%	3980

Other funds holding NRXS

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Money Concepts Capital Palm Beach Gardens, Florida $2.17B AUM 20.96% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Parsons Capital Management Providence, Rhode Island $2.29B AUM 21.99% 1-Year Est. Return

Eddie Patel Inc Chicago, Illinois $158M AUM 69.99% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

Mount Yale Investment Advisors Denver, Colorado $5.96B AUM 22.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Wealthcare Advisory Partners West Chester, Pennsylvania $5.9B AUM 14.62% 1-Year Est. Return

State Street's NRXS Position: Q3 2026 in Review

State Street increased its Neuraxis (NRXS) stake by 7.9% in Q3 2026, buying an estimated $23.2K and bringing the position to 47,737 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #3754.

State Street first reported a position in NRXS in Q4 2025 and has held it in 4 quarters since. 19 funds tracked by Wall St. Rank hold NRXS as of Q3 2026.

State Street held 47,737 shares of Neuraxis worth $352K as of Q3 2026.
State Street bought 3,500 Neuraxis shares in Q3 2026, an estimated $23.2K.
Neuraxis made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3754 holding.
State Street first reported a position in Neuraxis in Q4 2025 and has held it in 4 quarters since.
19 funds tracked by Wall St. Rank held Neuraxis as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.